Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-25-003874
Filing Date
2025-11-17
Accepted
2025-11-17 07:12:44
Documents
3
Period of Report
2025-11-17

Document Format Files

Seq Description Document Type Size
1 6-K zk2534026.htm 6-K 11210
2 PRESS RELEASE exhibit_99-1.htm EX-99.1 15328
3 image0.jpg GRAPHIC 27798
  Complete submission text file 0001178913-25-003874.txt   66201
Mailing Address 2 HAMAAYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN Israel ISRAEL
Business Address 2 HAMAAYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN Israel ISRAEL 972-8-642-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 251489309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)